- Home
- CODA vs HLVX Comparison
CODA vs HLVX Comparison
Compare CODA & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- HLVX
- Stock Information
- Founded
- CODA 1994
- HLVX 2020
- Country
- CODA United States
- HLVX United States
- Employees
- CODA N/A
- HLVX N/A
- Industry
- CODA Industrial Machinery/Components
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- HLVX Health Care
- Exchange
- CODA Nasdaq
- HLVX Nasdaq
- Market Cap
- CODA 88.7M
- HLVX 83.7M
- IPO Year
- CODA N/A
- HLVX 2022
- Fundamental
- Price
- CODA $8.10
- HLVX $2.09
- Analyst Decision
- CODA Strong Buy
- HLVX Hold
- Analyst Count
- CODA 1
- HLVX 5
- Target Price
- CODA $11.00
- HLVX $2.33
- AVG Volume (30 Days)
- CODA 59.6K
- HLVX 430.4K
- Earning Date
- CODA 06-16-2025
- HLVX 08-07-2025
- Dividend Yield
- CODA N/A
- HLVX N/A
- EPS Growth
- CODA 21.86
- HLVX N/A
- EPS
- CODA 0.30
- HLVX N/A
- Revenue
- CODA $22,758,966.00
- HLVX N/A
- Revenue This Year
- CODA $11.64
- HLVX N/A
- Revenue Next Year
- CODA $14.53
- HLVX N/A
- P/E Ratio
- CODA $26.83
- HLVX N/A
- Revenue Growth
- CODA 24.78
- HLVX N/A
- 52 Week Low
- CODA $5.76
- HLVX $1.34
- 52 Week High
- CODA $9.89
- HLVX $2.15
- Technical
- Relative Strength Index (RSI)
- CODA 57.37
- HLVX 63.08
- Support Level
- CODA $7.81
- HLVX $1.98
- Resistance Level
- CODA $8.50
- HLVX $2.12
- Average True Range (ATR)
- CODA 0.41
- HLVX 0.08
- MACD
- CODA -0.01
- HLVX 0.01
- Stochastic Oscillator
- CODA 63.45
- HLVX 89.66
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.